StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.78+0.01 (+1.18%)

Close on Nov 17, 2026Market cap $9.26MP/E –Yield –

CytoMed Therapeutics cash

Cash and short-term investments held at the end of each period.

CytoMed Therapeutics's cash was 2.10M SGD at Dec 31, 2025. For fiscal 2025 it was 2.10M SGD, down 55.4% from the year before. The highest annual figure on record is 6.22M SGD in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 20252.10M SGD-55.4%
FY2024Dec 31, 20244.70M SGD-24.5%
FY2023Dec 31, 20236.22M SGD+294.0%
FY2022Dec 31, 20221.58M SGD-37.1%
FY2021Dec 31, 20212.51M SGD+183.8%
FY2020Dec 31, 2020885.27K SGD+138.7%
FY2019Dec 31, 2019370.94K SGD–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 20252.10M SGD-16.6%
Q4 FY2024Dec 31, 20244.70M SGD+430.6%
Q4 FY2023Dec 31, 20236.22M SGD+1577.9%
Q4 FY2022Dec 31, 20221.58M SGD–
Q4 FY2021Dec 31, 20212.51M SGD–
Q4 FY2020Dec 31, 2020885.27K SGD–
Q4 FY2019Dec 31, 2019370.94K SGD–

More CytoMed Therapeutics figures

See a number that looks wrong?